Screening for colorectal cancer by faecal occult blood test: comparison of immunochemical tests

被引:42
作者
Castiglione, G [1 ]
Zappa, M [1 ]
Grazzini, G [1 ]
Rubeca, T [1 ]
Turco, P [1 ]
Sani, C [1 ]
Ciatto, S [1 ]
机构
[1] Azienda Osped Careggi, Presidio Prevenz Oncol, I-50131 Florence, Italy
关键词
colorectal cancer; faecal occult blood test; immunochemical tests;
D O I
10.1136/jms.7.1.35
中图分类号
R1 [预防医学、卫生学];
学科分类号
1004 ; 120402 ;
摘要
Objective-To compare two immunochemical faecal occult blood tests based on reversed passive haemagglutination (RPHA) or latex agglutination (Hdia) in a population based screening setting. Method-Hdia was interpreted according to three positivity thresholds: 100, 150, or 200 ng of haemoglobin/mg of specimen solution. A total of 5844 subjects were recruited into the study, from 17 432 invited subjects aged 50-70. Results-Positivity rates were 3.3% for RPHA, Hdia100 3.5%, Hdia150 2.5%, Hdia200 2.0%. Among subjects complying with the diagnostic work up, colorectal cancer (CRC) was detected in 19 subjects (17 RPHA positive, 16 Hdia100 positive, 15 Hdia150 positive, 14 Hdia200 positive) and high risk adenoma/s in 41 subjects (28 RPHA positive, 32 Hdia100 positive, 29 Hdia150 positive, 25 Hdia200 positive). The prevalence of screen positive CRC in the population was for RPHA 2.9 parts per thousand, Hdia100 2.7 parts per thousand, Hdia150 2.6 parts per thousand, Hdia200 2.4 parts per thousand. The prevalence of screen positive high risk adenomas in the population was for RPHA 4.8 parts per thousand, Hdia100 5.5 parts per thousand, Hdia150 5.0 parts per thousand, Hdia200 4.3 parts per thousand. Conclusion-Hdia100 was as sensitive as RPHA for cancer and high risk adenomas. As Hdia is less technically complex than RPHA, it is a valid alternative to the latter, provided that full automation of the development procedure is available. Increasing the positivity threshold of Hdia up to 150 or 200 ng of haemoglobin/mg of specimen solution is not advisable as the increase in specificity is too small to justify the corresponding decrease in the detection of screen positive cancers in the population.
引用
收藏
页码:35 / 37
页数:3
相关论文
共 23 条
[1]   A comparison of fecal occult-blood tests for colorectal-cancer screening [J].
Allison, JE ;
Tekawa, IS ;
Ransom, LJ ;
Adrain, AL .
NEW ENGLAND JOURNAL OF MEDICINE, 1996, 334 (03) :155-159
[2]   Reducing colorectal cancer mortality by repeated faecal occult blood test: a nested case-control study [J].
Bertario, L ;
Russo, A ;
Crosignani, P ;
Sala, P ;
Spinelli, P ;
Pizzetti, P ;
Andreola, S ;
Berrino, F .
EUROPEAN JOURNAL OF CANCER, 1999, 35 (06) :973-977
[3]  
CAMPBELL MJ, 1993, MED STAT, P148
[4]  
Castiglione G, 1994, Eur J Cancer Prev, V3, P399, DOI 10.1097/00008469-199409000-00003
[5]  
Castiglione G, 1997, J Med Screen, V4, P142
[6]   Immunochemical vs guaiac faecal occult blood tests in a population-based screening programme for colorectal cancer [J].
Castiglione, G ;
Zappa, M ;
Grazzini, G ;
Mazzotta, A ;
Biagini, M ;
Salvadori, P ;
Ciatto, S .
BRITISH JOURNAL OF CANCER, 1996, 74 (01) :141-144
[7]   Faecal occult blood screening and reduction of colorectal cancer mortality: a case control study [J].
Faivre, J ;
Tazi, MA ;
El Mrini, T ;
Lejeune, C ;
Benhamiche, AM ;
Dassonville, F .
BRITISH JOURNAL OF CANCER, 1999, 79 (3-4) :680-683
[8]   Randomised controlled trial of faecal-occult-blood screening for colorectal cancer [J].
Hardcastle, JD ;
Chamberlain, JO ;
Robinson, MHE ;
Moss, SM ;
Amar, SS ;
Balfour, TW ;
James, PD ;
Mangham, CM .
LANCET, 1996, 348 (9040) :1472-1477
[9]  
Itoh M, 1996, J Med Screen, V3, P66
[10]   Randomised study of screening for colorectal cancer with faecal-occult-blood test [J].
Kronborg, O ;
Fenger, C ;
Olsen, J ;
Jorgensen, OD ;
Sondergaard, O .
LANCET, 1996, 348 (9040) :1467-1471